Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
European Journal of Immunology
|
May 25, 2011
The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function
Jessica Herrath, Malin Müller, Petra Amoudruz, et al.
FEMS Immunology and Medical Microbiology
|
November 13, 2007
Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis
Philip J Bergin, Sukanya Raghavan, Helena Svensson, et al.
Cancer Immunology, Immunotherapy : CII
|
April 20, 2018
Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APC<sup>min/+</sup> mice
Paulina Akeus, Louis Szeponik, Filip Ahlmanner, et al.
Oncotarget
|
January 18, 2019
CD39<sup>+</sup> regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function
Filip Ahlmanner, Patrik Sundström, Paulina Akeus, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 12, 2025
Coordinated humoral and cellular immune responses to COVID-19 vaccination in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Anna Lundgren, Susannah Leach, Joanna Kaim, et al.
NPJ Vaccines
|
November 1, 2019
An oral alpha-galactosylceramide adjuvanted <i>Helicobacter pylori</i> vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses
Stephanie Longet, Aine Abautret-Daly, Christopher J H Davitt, et al.
Frontiers in Oncology
|
February 27, 2023
Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer
Nikita Dutta, Anna Rohlin, Ella A Eklund, et al.
Cancer Immunology, Immunotherapy : CII
|
September 13, 2025
High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancer
Nikita Dutta, Johanna Svensson, George-Alehandro Saad, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 11, 2025
Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival
Ella A Eklund, Mathilda Orgard, Delice Wallin, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 26, 2025
Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer
Ella A Eklund, Johanna Svensson, Louise Stauber Näslund, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
European Journal of Immunology
|
May 25, 2011
The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function
Jessica Herrath, Malin Müller, Petra Amoudruz, et al.
FEMS Immunology and Medical Microbiology
|
November 13, 2007
Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis
Philip J Bergin, Sukanya Raghavan, Helena Svensson, et al.
Cancer Immunology, Immunotherapy : CII
|
April 20, 2018
Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APC<sup>min/+</sup> mice
Paulina Akeus, Louis Szeponik, Filip Ahlmanner, et al.
Oncotarget
|
January 18, 2019
CD39<sup>+</sup> regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function
Filip Ahlmanner, Patrik Sundström, Paulina Akeus, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 12, 2025
Coordinated humoral and cellular immune responses to COVID-19 vaccination in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Anna Lundgren, Susannah Leach, Joanna Kaim, et al.
NPJ Vaccines
|
November 1, 2019
An oral alpha-galactosylceramide adjuvanted <i>Helicobacter pylori</i> vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses
Stephanie Longet, Aine Abautret-Daly, Christopher J H Davitt, et al.
Frontiers in Oncology
|
February 27, 2023
Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer
Nikita Dutta, Anna Rohlin, Ella A Eklund, et al.
Cancer Immunology, Immunotherapy : CII
|
September 13, 2025
High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancer
Nikita Dutta, Johanna Svensson, George-Alehandro Saad, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 11, 2025
Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival
Ella A Eklund, Mathilda Orgard, Delice Wallin, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 26, 2025
Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer
Ella A Eklund, Johanna Svensson, Louise Stauber Näslund, et al.
Page
of 5